Pharmacokinetics of Retapamulin in Pediatric Subjects With Uncomplicated Skin Infections. - Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00555061

Locations


United States, Alabama
	GSK Investigational Site
	Tuscaloosa, Alabama, United States, 35401

United States, Arkansas
	GSK Investigational Site
	Bentonville, Arkansas, United States, 72712

United States, California
	GSK Investigational Site
	Orange, California, United States, 92868

United States, Massachusetts
	GSK Investigational Site
	Woburn, Massachusetts, United States, 01801

United States, Ohio
	GSK Investigational Site
	Cleveland, Ohio, United States, 44106

United States, Texas
	GSK Investigational Site
	Houston, Texas, United States, 77090

Argentina, Buenos Aires
	GSK Investigational Site
	Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
	GSK Investigational Site
	Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina, C1425BEA

Chile, Región Metro De Santiago
	GSK Investigational Site
	Santiago, Región Metro De Santiago, Chile

Costa Rica
	GSK Investigational Site
	San Jose, Costa Rica

Germany, Nordrhein-Westfalen
	GSK Investigational Site
	Goch, Nordrhein-Westfalen, Germany, 47574
	GSK Investigational Site
	Bochum, Nordrhein-Westfalen, Germany, 44791

Mexico
	GSK Investigational Site
	Mexico, Mexico, 6720

Netherlands
	GSK Investigational Site
	ROTTERDAM, Netherlands, 3011 TD
	GSK Investigational Site
	ROELOFARENDSVEEN, Netherlands, 2371 RB
	GSK Investigational Site
	SOERENDONK, Netherlands, 6027 RN
	GSK Investigational Site
	WOERDEN, Netherlands, 3443 GG
	GSK Investigational Site
	ALPHEN A/D RIJN, Netherlands, 2403 JK
	GSK Investigational Site
	LOSSER, Netherlands, 7581 BV

South Africa
	GSK Investigational Site
	NEWTOWN, South Africa, 2113
	GSK Investigational Site
	Benoni, South Africa, 1500

Sponsors and Collaborators

GlaxoSmithKline

Investigators


Study Director:	GSK Clinical Trials, MD	GlaxoSmithKline